Primary skeletal muscle myoblasts from chronic heart failure patients exhibit loss of anti-inflammatory and proliferative activity

BMC Cardiovascular Disorders

Volumn 16, Issue 1, 2016, Pages

  Sente, Tahnee ^a,b   Van Berendoncks, An M ^a   Jonckheere, An I ^c   Rodenburg, Richard J ^d   Lauwers, Patrick ^a   Van Hoof, Viviane ^a   Wouters, An ^b   Lardon, Filip ^b   Hoymans, Vicky Y ^a   Vrints, Christiaan J ^a,b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic heart failure; Muscle wasting; Myoblast cultures; XCELLigence

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR 2; IL6 PROTEIN, HUMAN; MYOGENIC FACTOR; PAX3 PROTEIN, HUMAN; PAX7 PROTEIN, HUMAN; TNFRSF1B PROTEIN, HUMAN; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7;

ACTIN FILAMENT; ACTIN MICROFILAMENT; ADULT; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL SHAPE; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DONOR; FEMALE; GROWTH CURVE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; INFLAMMATION; MALE; MORPHOLOGY; MUSCLE BIOPSY; MYOTUBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MYOBLAST; VASTUS LATERALIS MUSCLE; CASE CONTROL STUDY; CELL AGING; CELL CULTURE; CHRONIC DISEASE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; METABOLISM; MIDDLE AGED; MUSCLE ATROPHY; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PRIMARY CELL CULTURE; QUADRICEPS FEMORIS MUSCLE; SIGNAL TRANSDUCTION; TIME FACTOR;

CASE-CONTROL STUDIES; CELL AGING; CELL PROLIFERATION; CELLS, CULTURED; CHRONIC DISEASE; FEMALE; HEART FAILURE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; MUSCULAR ATROPHY; MYOBLASTS, SKELETAL; MYOGENIC REGULATORY FACTORS; PAX3 TRANSCRIPTION FACTOR; PAX7 TRANSCRIPTION FACTOR; PHENOTYPE; PRIMARY CELL CULTURE; QUADRICEPS MUSCLE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84973400113     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-016-0278-3     Document Type: Article

References (58)

1. Conraads VM, Bosmans JM, Vrints CJ. Chronic heart failure: an example of a systemic chronic inflammatory disease resulting in cachexia. Int J Cardiol. 2002;85(1):33-49.
2. Wust RC, Degens H. Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis. 2007;2(3):289-300.
3. Upadhya B, Haykowsky MJ, Eggebeen J, Kitzman DW. Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem. Am J Geriatr Cardiol. 2015;12(3):294-304.
4. Dodson S, Baracos VE, Jatoi A, Evans WJ, Cella D, Dalton JT, Steiner MS. Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med. 2011;62:265-79.
5. von Haehling S, Doehner W, Anker SD. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res. 2007;73(2):298-309.
6. Fulster S, Tacke M, Sandek A, Ebner N, Tschope C, Doehner W, Anker SD, von Haehling S. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J. 2013;34(7):512-9.
7. Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation. 1992;85(4):1364-73.
8. Lauren Cornall DH, Michael Mathai and Andrew McAinch.: Generation and Use of Cultured Human Primary Myotubes. In: Muscle Biopsy. edn.; 2012: 35-64.
9. Danoviz ME, Yablonka-Reuveni Z. Skeletal muscle satellite cells: background and methods for isolation and analysis in a primary culture system. Methods Mol Biol. 2012;798:21-52.
10. Yablonka-Reuveni Z. Isolation and culture of myogenic stem cells. In: Lanza RBH, Melton D, Moore M, Thomas ED, Verfaillie C, Weissman IL, editors. Handbook of Stem Cells. San Diego: Elsevier, Academic Press; 2004. p. 571-80.
11. Barro M, Carnac G, Flavier S, Mercier J, Vassetzky Y, Laoudj-Chenivesse D. Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects. J Cell Mol Med. 2010;14(1-2):275-89.
12. Berggren JR, Tanner CJ, Houmard JA. Primary cell cultures in the study of human muscle metabolism. Exerc Sport Sci Rev. 2007;35(2):56-61.
13. McAinch AJ, Steinberg GR, Mollica J, O'Brien PE, Dixon JB, Kemp BE, Cameron-Smith D. Leptin stimulation of COXIV is impaired in obese skeletal muscle myotubes. Obesity Res Clin Pract. 2007;1(1):1-78.
14. Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest. 1975;35(7):609-16.
15. Gaster M, Beck-Nielsen H, Schroder HD. Proliferation conditions for human satellite cells. The fractional content of satellite cells. Acta Pathol Microbiol Immunol Scand. 2001;109(11):726-34.
16. Filigheddu N, Gnocchi VF, Coscia M, Cappelli M, Porporato PE, Taulli R, Traini S, Baldanzi G, Chianale F, Cutrupi S, et al. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell. 2007;18(3):986-94.
17. Yip DJ, Picketts DJ. Increasing D4Z4 repeat copy number compromises C2C12 myoblast differentiation. FEBS Lett. 2003;537(1-3):133-8.
18. Limame R, Wouters A, Pauwels B, Fransen E, Peeters M, Lardon F, De Wever O, Pauwels P. Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PLoS One. 2012;7(10):e46536.
19. Berendse M, Grounds MD, Lloyd CM. Myoblast structure affects subsequent skeletal myotube morphology and sarcomere assembly. Exp Cell Res. 2003;291(2):435-50.
20. Pomies P, Rodriguez J, Blaquiere M, Sedraoui S, Gouzi F, Carnac G, Laoudj-Chenivesse D, Mercier J, Prefaut C, Hayot M. Reduced myotube diameter, atrophic signalling and elevated oxidative stress in cultured satellite cells from COPD patients. J Cell Mol Med. 2015;19(1):175-86.
21. Thingholm TE, Bak S, Beck-Nielsen H, Jensen ON, Gaster M: Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods. Mol. Cell. Proteomics 2011, 10(9):M110 006650.
22. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93(4):704-11.
23. Putko BN, Wang Z, Lo J, Anderson T, Becher H, Dyck JR, Kassiri Z, Oudit GY, Alberta HI. Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology. PLoS One. 2014;9(6):e99495.
24. Hehlgans T, Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology. 2005;115(1):1-20.
25. Mizoguchi E, Mizoguchi A, Takedatsu H, Cario E, de Jong YP, Ooi CJ, Xavier RJ, Terhorst C, Podolsky DK, Bhan AK. Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice. Gastroenterology. 2002;122(1):134-44.
26. Otis JS, Niccoli S, Hawdon N, Sarvas JL, Frye MA, Chicco AJ, Lees SJ. Pro-inflammatory mediation of myoblast proliferation. PLoS One. 2014;9(3):e92363.
27. Toth KG, McKay BR, De Lisio M, Little JP, Tarnopolsky MA, Parise G. IL-6 induced STAT3 signalling is associated with the proliferation of human muscle satellite cells following acute muscle damage. PLoS One. 2011;6(3):e17392.
28. Tierney MT, Aydogdu T, Sala D, Malecova B, Gatto S, Puri PL, Latella L, Sacco A. STAT3 signaling controls satellite cell expansion and skeletal muscle repair. Nat Med. 2014;20(10):1182-6.
29. Serrano AL, Baeza-Raja B, Perdiguero E, Jardi M, Munoz-Canoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 2008;7(1):33-44.
30. Gielen S, Adams V, Mobius-Winkler S, Linke A, Erbs S, Yu J, Kempf W, Schubert A, Schuler G, Hambrecht R. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol. 2003;42(5):861-8.
31. Timmerman KL, Dhanani S, Glynn EL, Fry CS, Drummond MJ, Jennings K, Rasmussen BB, Volpi E. A moderate acute increase in physical activity enhances nutritive flow and the muscle protein anabolic response to mixed nutrient intake in older adults. Am J Clin Nutr. 2012;95(6):1403-12.
32. Hamilton KE, Simmons JG, Ding S, Van Landeghem L, Lund PK. Cytokine induction of tumor necrosis factor receptor 2 is mediated by STAT3 in colon cancer cells. Mol Cancer Res. 2011;9(12):1718-31.
33. Carty SE, Buresh CM, Norton JA. Decreased IL-6 secretion by fibroblasts following repeated doses of TNF alpha or IL-1 alpha: post-transcriptional gene regulation. J Surg Res. 1991;51(1):24-32.
34. Kitzman DW, Nicklas B, Kraus WE, Lyles MF, Eggebeen J, Morgan TM, Haykowsky M. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2014;306(9):H1364-70.
35. Okita K, Kinugawa S, Tsutsui H. Exercise intolerance in chronic heart failure--skeletal muscle dysfunction and potential therapies. Circ J. 2013;77(2):293-300.
36. Pandey A, Garg S, Khunger M, Darden D, Ayers C, Kumbhani DJ, Mayo HG, de Lemos JA, Berry JD. Dose-Response Relationship Between Physical Activity and Risk of Heart Failure: A Meta-Analysis. Circulation. 2015;132(19):1786-94.
37. Rahman I, Bellavia A, Wolk A, Orsini N. Physical Activity and Heart Failure Risk in a Prospective Study of Men. JACC Heart Failure. 2015;3(9):681-7.
38. Kadi F, Charifi N, Denis C, Lexell J, Andersen JL, Schjerling P, Olsen S, Kjaer M. The behaviour of satellite cells in response to exercise: what have we learned from human studies? Pflugers Arch - Eur J Physiol. 2005;451(2):319-27.
39. Snijders T, Verdijk LB, Beelen M, McKay BR, Parise G, Kadi F, van Loon LJ. A single bout of exercise activates skeletal muscle satellite cells during subsequent overnight recovery. Exp Physiol. 2012;97(6):762-73.
40. Peake JM, Della Gatta P, Suzuki K, Nieman DC. Cytokine expression and secretion by skeletal muscle cells: regulatory mechanisms and exercise effects. Exerc Immunol Rev. 2015;21:8-25.
41. Kadi F, Schjerling P, Andersen LL, Charifi N, Madsen JL, Christensen LR, Andersen JL. The effects of heavy resistance training and detraining on satellite cells in human skeletal muscles. J Physiol-London. 2004;558(3):1005-12.
42. Crameri RM, Langberg H, Magnusson P, Jensen CH, Schroder HD, Olesen JL, Suetta C, Teisner B, Kjaer M. Changes in satellite cells in human skeletal muscle after a single bout of high intensity exercise. J Physiol-London. 2004;558(1):333-40.
43. Begue G, Douillard A, Galbes O, Rossano B, Vernus B, Candau R, Py G. Early activation of rat skeletal muscle IL-6/STAT1/STAT3 dependent gene expression in resistance exercise linked to hypertrophy. PLoS One. 2013;8(2):e57141.
44. Will K, Kalbe C, Kuzinski J, Losel D, Viergutz T, Palin MF, Rehfeldt C. Effects of leptin and adiponectin on proliferation and protein metabolism of porcine myoblasts. Histochem Cell Biol. 2012;138(2):271-87.
45. Baeza-Raja B, Munoz-Canoves P. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6. Mol Biol Cell. 2004;15(4):2013-26.
46. Laustsen PG, Russell SJ, Cui L, Entingh-Pearsall A, Holzenberger M, Liao R, Kahn CR. Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function. Mol Cell Biol. 2007;27(5):1649-64.
47. Machida S, Booth FW. Insulin-like growth factor 1 and muscle growth: implication for satellite cell proliferation. Proc Nutr Soc. 2004;63(2):337-40.
48. Conejo R, Valverde AM, Benito M, Lorenzo M. Insulin produces myogenesis in C2C12 myoblasts by induction of NF-kappaB and downregulation of AP-1 activities. J Cell Physiol. 2001;186(1):82-94.
49. Grabiec K, Gajewska M, Milewska M, Blaszczyk M, Grzelkowska-Kowalczyk K. The influence of high glucose and high insulin on mechanisms controlling cell cycle progression and arrest in mouse C2C12 myoblasts: the comparison with IGF-I effect. J Endocrinol Investig. 2014;37(3):233-45.
50. Taylor WE, Bhasin S, Artaza J, Byhower F, Azam M, Willard Jr DH, Kull Jr FC, Gonzalez-Cadavid N. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab. 2001;280(2):E221-8.
51. Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, Kambadur R. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem. 2000;275(51):40235-43.
52. McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R. Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol. 2003;162(6):1135-47.
53. Baba TT, Nemoto TK, Miyazaki T, Oida S. Simvastatin suppresses the differentiation of C2C12 myoblast cells via a Rac pathway. J Muscle Res Cell Motil. 2008;29(2-5):127-34.
54. Schirris TJ, Renkema GH, Ritschel T, Voermans NC, Bilos A, van Engelen BG, Brandt U, Koopman WJ, Beyrath JD, Rodenburg RJ, et al. Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition. Cell Metab. 2015;22(3):399-407.
55. Taha DA, De Moor CH, Barrett DA, Gershkovich P. Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies. Transl Res. 2014;164(2):85-109.
56. Parker BA, Thompson PD. Effect of statins on skeletal muscle: exercise, myopathy, and muscle outcomes. Exerc Sport Sci Rev. 2012;40(4):188-94.
57. Gaster M, Petersen I, Hojlund K, Poulsen P, Beck-Nielsen H. The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes. 2002;51(4):921-7.
58. Zhang L, Wang XH, Wang H, Du J, Mitch WE. Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy. J Am Soc Nephrol. 2010;21(3):419-27.